North America Anti-Vascular Endothelial Growth Factor Therapeutics Market Size & Outlook
The anti-vascular endothelial growth factor therapeutics market in North America is expected to reach a projected revenue of US$ 9,124.8 million by 2030. A compound annual growth rate of -1.2% is expected of North America anti-vascular endothelial growth factor therapeutics market from 2025 to 2030.
- Pharmaceuticals
- Ophthalmology Drugs
- Anti-Vascular Endothelial Growth Factor Therapeutics Market Outlook
- Ophthalmology Drugs